This is the first study in Vietnam with a sample size large enough to reach the most complete results on the effectiveness of sorafenib and the affective factors on the result treatment in Vietnamese patients with hepatocellular carcinoma. And this is the first study discuss the controversial issues in sorafenib treatment in Vietnam 2.